MARSSI: Evaluation of Momentary Affect Regulation - Safer Sex Intervention

Sponsor
The Policy & Research Group (Other)
Overall Status
Recruiting
CT.gov ID
NCT04798248
Collaborator
Office of Population Affairs (Other), Mathematica Policy Research, Inc. (Other)
600
2
2
24.3
300
12.3

Study Details

Study Description

Brief Summary

The purpose of the study is to determine the impact of the offer to participate in the Momentary Affect Regulation - Safer Sex Intervention (treatment) relative to the offer to participate in the control condition on participants' reported condom use, use of effective contraception, and number of sexual partners three months after the end of the treatment intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Momentary Affect Regulation - Safer Sex Intervention (MARSSI)
  • Behavioral: Podcast Health Group
N/A

Detailed Description

The Policy & Research Group (PRG) will be conducting a rigorous evaluation of an innovative intervention designed to reduce unplanned pregnancy and sexually transmitted infections in young women with depression, entitled Momentary Affect Regulation - Safer Sex Intervention (MARSSI). MARSSI was developed by Dr. Lydia Shrier of Boston Children's Hospital. MARSSI has three components. The first is a manualized session with a sexual and reproductive health counselor, who uses motivational interviewing (MI) techniques to help the young woman identify a risk-reducing goal for her sexual behavior, develop a change plan, and provide depression education and skills, based on cognitive behavioral therapy. The second component is a mobile health (mhealth) application that the young woman loads on her smartphone and, for four weeks, uses to complete app-prompted reports 3 times a day and a scheduled report once a day. When she reports poor affect, low contraceptive or condom self-efficacy, pregnancy desire, or desire for sex to regulate affect, she receives personalized messages prompting healthy behaviors and cognitive behavioral skill use. The third component is a booster session that occurs after 4 weeks of app use. The young woman meets with the counselor again to review her behavior and relationships, discuss progress toward her goal, and learn a new skill. Through these components, MARSSI aims to enhance motivation to change risk behaviors, provides skills to address depression's effects on behavior, and prompts and reinforces healthy affect regulation, cognitive behavioral skill use, and behavior change in daily life.

The Policy & Research Group (PRG) will conduct an implementation evaluation and an impact evaluation, using an individual randomized controlled trial, to test the efficacy of this new intervention. The study will target young women ages 17-20 who have depressive symptoms and are recent clients of sexual and reproductive health clinics. The primary focus of the study will be to investigate the impact of the intervention on three self-reported sexual behaviors: 1) condom use; 2) use of effective contraception; and 3) number of sexual partners. The study will also include exploratory investigations of a number of other sexual behaviors and theoretically relevant antecedents to change in behavior and sexual health, including but not limited to: 1) engagement in protective sexual behavior; 2) condom use at last vaginal sex; 3) effective contraceptive use at last vaginal sex; 4) dual methods of protection; 5) frequency of vaginal, anal, and oral sex; 6) substance use before any type of sex; 7) types of sexual partners/relationships; 8) depressive symptoms; 9) sexual communication self-efficacy; 10) motivation to change risky sexual behaviors; 11) contraceptive and condom knowledge; 12) contraceptive and condom planning self-efficacy; and 13) use of cognitive restructuring.

Outcomes will be assessed using self-reported, participant-level data gathered (by way of a questionnaire) at four time points: baseline (enrollment); post-program (immediately after the end of the intervention period; 1 month post baseline); short-term (4 months post-baseline) follow-up; and long-term (7 months post baseline) follow-up.

Starting in May 2021 and continuing for 17 months, 600 participants who have received recent sexual or reproductive health care from any Planned Parenthood health center (nationally) will be recruited and enrolled into the study by trained Planned Parenthood research coordinators. The final year of the grant will be used to complete the following tasks: collect follow-up data from study participants; conduct implementation and impact evaluation analysis, reporting, and dissemination efforts; and manualize and package the curriculum and training materials.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
600 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Evaluation of Momentary Affect Regulation - Safer Sex Intervention
Actual Study Start Date :
Jun 19, 2021
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Momentary Affect Regulation - Safer Sex Intervention

Momentary Affect Regulation - Safer Sex Intervention (MARSSI) is the treatment condition. MARSSI aims to enhance an individual's motivation to change risk behaviors, provides skills to address depression's effects on behavior, and prompts and reinforces healthy affect regulation, cognitive behavioral skill use, and behavior change in daily life.

Behavioral: Momentary Affect Regulation - Safer Sex Intervention (MARSSI)
MARSSI is an individual-level intervention that involves a one-hour manualized session with a sexual reproductive health (SRH) counselor, followed by one-month of daily use of a mobile health app and a final 20-minute booster session with the SRH counselor.

Sham Comparator: Podcast Health Group

The Podcast Health Group is the control counterfactual condition.

Behavioral: Podcast Health Group
Participants assigned to the Podcast Health Group will listen to ~20 minute podcast episode put out by the Susan G. Komen Foundation about family history of breast cancer; the podcast does not include information related to the outcomes of interest for the study.

Outcome Measures

Primary Outcome Measures

  1. Times having vaginal sex without a condom [Assessed three months after the intervention period has ended]

    Participant self-report on the number of times having vaginal sex without using a condom during the past 30 days

  2. Number of sexual partners [Assessed three months after the intervention period has ended]

    Participant self-report of the number of sexual partners in the the past three months

  3. Effective contraceptive use [Assessed three months after the intervention period has ended]

    Participant self-report on whether or not they are currently using effective (prescription) contraception or not

Eligibility Criteria

Criteria

Ages Eligible for Study:
17 Years to 20 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Be an active patient of a Planned Parenthood health center

  • Own a smartphone

  • Have the technical capacity to participate

  • Be fluent in English

  • Be 17 to 20 years of age

  • Be biologically able to become pregnant (to the best of their knowledge)

  • Score at least 8 on the PHQ-8

  • Have had penile-vaginal sex in the past 3 months

  • Have had penile-vaginal sex at least once a week, on average

  • Report having done at least one of the following during the 3 months preceding eligibility screening: 1) Not using a condom every time they have sexual intercourse;

  1. Used condoms, a diaphragm, cervical cap, spermicide, sponge, fertility awareness, or withdrawal as a primary form of birth control; 3) Had sexual intercourse with more than one person; 4) Had sexual intercourse within 2 hours after using drugs and alcohol; and/or 5) Been treated for an STI/STD
Exclusion Criteria:
  • Trying to get pregnant or currently pregnant at the time of eligibility screening

  • Have given birth during the 6 months preceding eligibility screening

  • Married or engaged to be married at the time of eligibility screening

Contacts and Locations

Locations

Site City State Country Postal Code
1 Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky Seattle Washington United States 98122
2 Planned Parenthood of Wisconsin Madison Wisconsin United States 53713

Sponsors and Collaborators

  • The Policy & Research Group
  • Office of Population Affairs
  • Mathematica Policy Research, Inc.

Investigators

  • Principal Investigator: Eric Jenner, PhD, The Policy & Research Group

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The Policy & Research Group
ClinicalTrials.gov Identifier:
NCT04798248
Other Study ID Numbers:
  • 1 TP2AH000076-01-00
First Posted:
Mar 15, 2021
Last Update Posted:
Jan 21, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 21, 2022